Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 14, 2013; 19(42): 7276-7281
Published online Nov 14, 2013. doi: 10.3748/wjg.v19.i42.7276
Published online Nov 14, 2013. doi: 10.3748/wjg.v19.i42.7276
Diagnosis and treatment of diabetes mellitus in chronic pancreatitis
Nils Ewald, Justus-Liebig-University Giessen, 35392 Giessen, Germany
Nils Ewald, Department of Internal Medicine, General Hospital Luebbecke-Rahden, 32312 Luebbecke, Germany
Philip D Hardt, Medical Department IV/V, Giessen and Marburg University Hospital, 32392 Giessen, Germany
Author contributions: All authors contributed to this review.
Correspondence to: Nils Ewald, MD, Associate Professor of Internal Medicine, Department of Internal Medicine, General Hospital Luebbecke-Rahden, Virchowstr. 65, 32312 Luebbecke, Germany. nils.ewald@innere.med.uni-giessen.de
Telephone: +49-5741-351100 Fax: +49-5741-352724
Received: June 10, 2013
Revised: August 13, 2013
Accepted: September 4, 2013
Published online: November 14, 2013
Processing time: 160 Days and 17.3 Hours
Revised: August 13, 2013
Accepted: September 4, 2013
Published online: November 14, 2013
Processing time: 160 Days and 17.3 Hours
Core Tip
Core tip: Type 3c diabetes mellitus is more common than generally thought. Its prevalence is supposed to be among 5%-10% among all diabetics. Most patients with type 3c diabetes mellitus suffer from chronic pancreatitis as the underlying disease. Misclassification of these patients is very common, yet identification of these patients is very important due to some special diagnostic and therapeutic considerations in this subset of patients. Among these are e.g., restoring proper fat assimilation, preventing fat-soluble vitamin deficiency and early identification of pancreatic cancer patients. Specific diagnostic criteria for type 3c diabetes mellitus are proposed within this review.